卫氏鱼康品牌怎么样 申请店铺

更新时间:2024-10-28
卫氏鱼康是哪个国家的品牌?「卫氏鱼康」是 山西卫氏鱼康实业有限公司 旗下著名品牌。该品牌发源于山西省运城市,由创始人卫静安在1999-02-26期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
卫氏鱼康怎么样

卫氏鱼康实业有限公司始建于1988年,是我国较早的鱼药生产企业,它的出现造就了鱼药行业的兴起,推动了中国鱼药市场。20多年来,鱼康产品行销全国各地,远销东南亚和前苏联地区。企业凭借深厚的文化底蕴及雄厚的产品研发实力,“鱼康”品牌巍然屹立于中国鱼药市场20多年。

近年来,公司不断增加科技投入,与多家专业院校和科研机构合作,以市场为导向,需求为宗旨,共同研制开发安全、环保的产品,带领行业发展方向。“噬菌蛭弧菌粉”、“脱氮菌粉”一经投入市场,便在经营户和养殖户中好评如潮,为企业发展再添助力,为中国鱼药市场再开新天地。

客户至上,信誉至上,是公司一贯秉承的企业文化;仁义礼智信,是公司一贯坚守的企业精神;创新带领、严谨科学是公司始终不变的研发方针;崇尚信誉,诚信服务是公司遵守的销售宗旨。


Weishiyukang Industry Co., Ltd. was founded in 1988. It is an early fish medicine manufacturer in China. Its emergence has created the rise of fish medicine industry and promoted the Chinese fish medicine market. Over the past 20 years, Yukang products have been sold all over the country, as far as Southeast Asia and the former Soviet Union. With its profound cultural heritage and strong product R & D strength, Yukang brand stands firm in the Chinese fish medicine market for more than 20 years. In recent years, the company has continuously increased investment in science and technology, cooperated with a number of professional colleges and research institutions, guided by the market and with the purpose of demand, jointly developed safe and environmental protection products, and led the development direction of the industry. The "bacteriophage" and "denitrifying bacteria powder" have been well received by operators and farmers in the market, which will help boost the development of enterprises and open up a new world for China's fish medicine market. Customer first, reputation first, is the corporate culture that the company has always adhered to; benevolence, righteousness, courtesy, wisdom and trust are the corporate spirit that the company has always adhered to; innovation leadership, rigorous science is the company's constant R & D policy; advocating reputation, integrity service is the sales purpose that the company abides by.

本文链接: https://brand.waitui.com/8c80a3ae2.html 联系电话:03594031111

千城特选小程序码

7×24h 快讯

上交所终止如鲲新材科创板发行上市审核

36氪获悉,据上交所,因上海如鲲新材料股份有限公司及其保荐人东方证券股份有限公司撤回发行上市申请,上交所终止其科创板发行上市审核。

33分钟前

万华化学:第三季度营收505.37亿元,同比增长12.48%

36氪获悉,万华化学发布第三季财报。财报显示,第三季度营收为505.37亿元,同比增长12.48%;净利润为29.19亿元,同比下降29.41%。前三季度营收为1476.04亿元,同比增长11.35%;净利润为110.93亿元,同比下降12.67%。

33分钟前

新安股份:控股子公司拟1.9亿元收购传化嘉易100%股东权益

36氪获悉,新安股份公告,公司控股子公司华洋化工拟出资1.9亿元,收购传化智联持有的传化嘉易100%股东权益。本次收购传化嘉易100%股权旨在解决制约控股子公司华洋化工发展战略的瓶颈问题,有利于其扩大生产规模,升级产品工艺,增强新产品的研发生产能力。本次交易构成关联交易,交易对方传化智联为公司控股股东传化集团的控股子公司。

33分钟前

南网储能:第三季度营业收入45.19亿元,同比增长11.12%

36氪获悉,南网储能发布2024年第三季度财报。报告显示,公司前三季度实现营业收入45.19亿元,同比增长11.12%;归属于上市公司股东的净利润10.45亿元,同比增长27.62%。第三季度实现营业收入16.08亿元,同比增长33.33%;归属于上市公司股东的净利润4.19亿元,同比增长231.49%。

33分钟前

上周无新增IPO申报企业

36氪获悉,上周(10月21日—10月27日)无新增IPO申报企业。截至10月27日,今年新增IPO申报企业35家。截至10月27日,各板块在审企业共277家。其中上交所77家(主板52家,科创板25家),深交所111家(主板36家,创业板75家),北交所89家。

33分钟前

本页详细列出关于卫氏鱼康的品牌信息,含品牌所属公司介绍,卫氏鱼康所处行业的品牌地位及优势。
咨询